BBWI Looks 44.4% Undervalued on GF Value™
Bath & Body Works Inc (BBWI) reported Q2 2026 earnings with net sales of $1.5B, down 2.3% YoY, but raised adjusted EPS guidance to $2.60-$2.80. The stock is undervalued with a GF Value of $34.04 vs. current price of $18.94, offering a 4.23% dividend yield. Insiders and gurus show confidence with net buying and increased positions.
How this was made
The 30-second read
Why it matters
Earnings release provides fresh data on sales, earnings, and guidance, influencing valuation and dividend appeal.
Market read
The earnings release introduces new financial metrics and guidance that can affect BBWI's stock price and dividend attractiveness.
What to watch
Tariff refunds and exit from low‑margin Home Care segment could improve margins over time.
Background
Bath & Body Works reported Q2 2026 results, highlighting a 2.3% YoY sales decline, EPS $0.62, dividend yield 4.23%, and revised guidance.
Ticker impact
Q2 2026 earnings released with net sales $1.5B, EPS $0.62, revised full-year sales guidance and raised EPS guidance.
Potential modest upside if investors focus on dividend yield and EPS raise; downside risk from sales guidance cut.
New earnings numbers and guidance are primary disclosures for a mid‑cap consumer cyclical stock, providing fresh material for trading decisions.
Market effects
Consumer cyclical sector may see pressure as BBWI cuts sales outlook, but dividend‑seeking investors could rotate into the stock.
North American retail sector could be modestly affected by BBWI's guidance revision.
Limited; primarily impacts US consumer discretionary investors.
Counterpoint
Despite sales decline, the high dividend yield and undervaluation may attract value investors, offsetting growth concerns.
Key entities
- CompanyBath & Body Works Inc
Consumer cyclical retailer reporting Q2 2026 earnings.
- ExecutiveCEO Daniel Heaf
Provided commentary on growth areas and segment exit.
